Literature DB >> 19738218

Responsiveness of the Effective Consumer Scale (EC-17).

Nancy Santesso1, Tamara Rader, George A Wells, Annette M O'Connor, Peter M Brooks, Michelle Driedger, Cindy Gallois, Elizabeth Kristjansson, Anne Lyddiatt, Gráinne O'Leary, Monica Prince, Dawn Stacey, Janet Wale, Vivian Welch, Andrew J Wilson, Peter S Tugwell.   

Abstract

OBJECTIVE: The Effective Consumer Scale (EC-17) comprises 17 items measuring the main skills and behaviors people need to effectively manage their healthcare. We tested the responsiveness of the EC-17.
METHODS: Participants, in 2 waves of a 6-week Arthritis Self-Management Program (ASMP) from Arthritis Ireland, received a questionnaire at the first and last week of the weekly ASMP. The questionnaire included the EC-17 and 10 other measures for arthritis. Deficits, mean change, and standard deviations were calculated at baseline and Week 6. The EC-17 scores were compared to the Arthritis Self-Efficacy (ASE) and Patient Activation Measure (PAM) scales. Results were presented at OMERACT 9.
RESULTS: There is some overlap between the EC-17 and the ASE and PAM; however, most items of greatest deficit in the EC-17 are not covered by those scales. In 327 participants representing both intervention waves (2006 and 2007), the EC-17 was more efficient than the ASE but less efficient than the PAM for detecting improvements after the ASMP, and was moderately correlated with the PAM.
CONCLUSION: The EC-17 appears to measure different skills and attributes than the ASE and PAM. Discussions with participants at OMERACT 9 agreed that it is worthwhile to measure the skills and attributes of an effective consumer, and supported the development of an intervention (such as proposed online decision aids) that would include education in the categories in the EC-17.

Entities:  

Mesh:

Year:  2009        PMID: 19738218     DOI: 10.3899/jrheum.090363

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  Comparison of multimedia and printed patient education tools for patients with osteoporosis: a 6-month randomized controlled trial.

Authors:  M A Lopez-Olivo; J K A des Bordes; H Lin; T Rizvi; R J Volk; M E Suarez-Almazor
Journal:  Osteoporos Int       Date:  2019-12-16       Impact factor: 4.507

Review 2.  Patient participation in clinical encounters: a systematic review to identify self-report measures.

Authors:  Brian Mavis; Margaret Holmes Rovner; Sarah Jorgenson; John Coffey; Nandita Anand; Emi Bulica; Carolyn Marie Gaulden; Jacob Peacock; Alycia Ernst
Journal:  Health Expect       Date:  2014-03-11       Impact factor: 3.377

3.  Development and Pilot Testing of Multimedia Patient Education Tools for Patients With Knee Osteoarthritis, Osteoporosis, and Rheumatoid Arthritis.

Authors:  Maria A Lopez-Olivo; Aparna Ingleshwar; Robert J Volk; Maria Jibaja-Weiss; Andrea Barbo; Kenneth Saag; Amye Leong; Maria E Suarez-Almazor
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-12-29       Impact factor: 4.794

4.  Effects of a one week multidisciplinary inpatient self-management programme for patients with fibromyalgia: a randomised controlled trial.

Authors:  Bente Hamnes; Petter Mowinckel; Ingvild Kjeken; Kåre B Hagen
Journal:  BMC Musculoskelet Disord       Date:  2012-09-26       Impact factor: 2.362

5.  Translation and validation of the Dutch version of the Effective Consumer Scale (EC-17).

Authors:  Peter M ten Klooster; Erik Taal; Liseth Siemons; Johanna C M Oostveen; Etelka J Harmsen; Peter S Tugwell; Tamara Rader; Anne Lyddiatt; Mart A F J van de Laar
Journal:  Qual Life Res       Date:  2012-03-28       Impact factor: 4.147

6.  Validity of a New Patient Engagement Measure: The Altarum Consumer Engagement (ACE) Measure.

Authors:  Christopher C Duke; Wendy D Lynch; Brad Smith; Julie Winstanley
Journal:  Patient       Date:  2015-12       Impact factor: 3.883

7.  Identification, description and appraisal of generic PROMs for primary care: a systematic review.

Authors:  Mairead Murphy; Sandra Hollinghurst; Chris Salisbury
Journal:  BMC Fam Pract       Date:  2018-03-15       Impact factor: 2.497

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.